Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.56 |
| ▸ | SLC18A3 | Q16572 | 3/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CCR3 | P51677 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13349193 | 1.00 | ALDH1A1 (0.58) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| SCHEMBL9195499 | 0.91 | ALDH1A1 (0.68) | ALDH1A1FUCA1SLC18A3BCHECYP1A2 | |
| SCHEMBL9202324 | 0.91 | ALDH1A1 (0.68) | ALDH1A1FUCA1SLC18A3BCHECYP1A2 | |
| SCHEMBL2178042 | 0.87 | FUCA1 (0.60) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| SCHEMBL1955799 | 0.87 | FUCA1 (0.60) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| SCHEMBL1710254 | 0.87 | FUCA1 (0.60) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| SCHEMBL9721734 | 0.87 | FUCA1 (0.60) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| SCHEMBL2178046 | 0.87 | FUCA1 (0.60) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| SCHEMBL2509822 | 0.87 | FUCA1 (0.60) | ALDH1A1FUCA1SLC18A3ACHEBCHE | |
| Hydrochloric Acid SCHEMBL3057890 | 0.86 | FUCA1 (0.58) | ALDH1A1FUCA1SLC18A3ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166357-A1 | METHOD FOR PRODUCING N-SUBSTITUTED-TRANS-4-AZIDOPIPERIDINE-3-OL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
| CN-100497331-C | 7-(4-oxime-3-amino-1-piperidine) quinoline carboxylic acid derivative and method for making same | BEIJING DOUBLE CRANE PHARMACEU (CN) | 2009-06-10 | — | — | CN | disclosed |
| CN-101117336-A | 7-(4-oxime-3-amino-1-piperidine) quinoline carboxylic acid derivative and method for making same | INST OF MEDICAL BIOTECHNOLOGY (CN) | 2008-02-06 | — | — | CN | disclosed |
| CN-101070322-A | 7-(4-nitroyl-3-amino-1-piperidyl) quinolinecarboxylic acid derivative, its preparing method and use | MEDICINE BIOLOG TECHNOLOGY I C (CN) | 2007-11-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166357-A1 | METHOD FOR PRODUCING N-SUBSTITUTED-TRANS-4-AZIDOPIPERIDINE-3-OL | RPS27L, OSGEP, RPLP1 | ALDH1A1 264/4885FUCA1 1451/4885SLC18A3 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.